Rachel A. Burga
Barricaid (United States)(US)Pliant (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Neuroblastoma Research and Treatments
Most-Cited Works
- → Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases(2015)376 cited
- → Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T(2015)220 cited
- → A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration(2012)154 cited
- → Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma(2016)145 cited
- → Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma(2017)127 cited
- → Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma(2021)104 cited
- → Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma(2019)81 cited
- → Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma(2020)68 cited
- → Conjugating Prussian Blue Nanoparticles Onto antigen-specific T Cells As a Combined Nanoimmunotherapy(2016)62 cited
- → Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils(2013)60 cited